Your voice in the tumor board: study tests if patient reports lead to better cancer treatment
NCT ID NCT07671937
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will include about 2,748 people with breast, gynecologic, or pancreatic cancer. Researchers want to see if adding patient-reported outcomes—like symptoms, preferences, and travel distance—to tumor board discussions helps doctors make better treatment decisions. The goal is to reduce treatment delays and side effects while improving patient experience.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
patient-reported outcomes (ePROs) integrated into tumor board discussions
What this could lead to
If successful, this could show that including patient feedback in treatment planning leads to better-tailored cancer care and fewer treatment side effects.
What could go wrong
This is an early-stage behavioral study, not a drug trial. It may not change actual treatment outcomes, and results may vary across different hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
-
University of California Los Angeles (UCLA)
Los Angeles, California, 90404, United States
Contact
Contact
Contact
-
University of Oklahoma (OU) Health Campus
Oklahoma City, Oklahoma, 73126-0901, United States
Contact
Contact